http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021100847-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d6bcba597c4e31ee03ec7fae57460339 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-115 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-25 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-44 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0665 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0663 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-15 |
| filingDate | 2020-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_09b981ecc4bfe9106147f60c42a8d658 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af89ebfb45d587e91e72935f3eb84a33 |
| publicationDate | 2021-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2021100847-A1 |
| titleOfInvention | Stem cells for the treatment of chronic traumatic encephalopathy |
| abstract | Disclosed are new, useful and non-obvious methodologies and compositions of matter for the treatment of chronic traumatic encephalopathy (CTE) using stem cells and cells possessing stem cell-like activity. The treatment of CTE is accomplished by utilizing stem cells to: a) reduce oxidative stress; b) suppress inflammation; c) enhance neurogenesis; and d) stimulate axonal regrowth. In one embodiment said stem cells are mesenchymal stem cells derived from umbilical cord and other perinatal tissues. In another embodiment, said stem cells are bone marrow derived. In yet another embodiment said stem cells are adipose derived. In one embodiment, products derived from said regenerative cells are comprised of cellular lysate, apoptotic bodies, exosomes, and other microvesicles. In one embodiment, said regenerative cells and/or said products derived from said regenerative cells are administered subsequent to one ore multiple head injuries. In other embodiments said products are administered in combination with neurorestorative and/or neuroprotective interventions. |
| priorityDate | 2019-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1159.